Neurogene Inc. (NASDAQ: NGNE)
$36.4200
-35.1000 ( -49.10% ) 823.0K
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
Market Data
Open
$36.4200
Previous close
$71.5300
Volume
823.0K
Market cap
$582.62M
Day range
$36.3150 - $49.5450
52 week range
$12.4900 - $74.4900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | Apr 22, 2024 |
| 8-k | 8K-related | 13 | Apr 02, 2024 |
| 8-k | 8K-related | 15 | Mar 18, 2024 |
| 10-k | Annual reports | 121 | Mar 18, 2024 |
| 4 | Insider transactions | 1 | Mar 14, 2024 |
| 4 | Insider transactions | 1 | Mar 14, 2024 |
| 4 | Insider transactions | 1 | Mar 14, 2024 |
| 8-k | 8K-related | 52 | Mar 04, 2024 |
| 8-k | 8K-related | 14 | Feb 21, 2024 |
| 3 | Insider transactions | 2 | Jan 18, 2024 |